Sylvie Chevret, MD, PhD

Head
ECSTRRA team, UMR1342 IRSL, INSERM, Paris Cité University, France, France

Poster(s):

• 1504 - What measure of treatment effect should be preferred ? A critical review of 20 randomized clinical trials of targeted therapies in chronic lymphocytic leukemia